Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. 2008

Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104. rileyj@mail.med.upenn.edu.

Rhesus TRIM5alpha (rhTRIM5alpha), but not human TRIM5alpha (huTRIM5alpha), potently inhibits human immunodeficiency virus (HIV) infection and is thus a potentially valuable therapeutic tool. Primary human CD4 T cells engineered to express rhTRIM5alpha were highly resistant to cell-free HIV type 1 (HIV-1) infection. However, when cocultured with unmodified T cells, rhTRIM5alpha-expressing cells became highly permissive to HIV-1 infection. Physical separation of rhTRIM5alpha-expressing cells and unmodified cells revealed that rhTRIM5alpha efficiently restricts cell-free but not cell-associated HIV transmission. Furthermore, we observed that HIV-infected human cells could infect rhesus CD4 T cells by cell-to-cell contact, but the infection was self-limiting. Subsequently, we noted that a spreading infection ensued when HIV-1-infected rhTRIM5alpha-expressing human cells were cultured with huTRIM5alpha- but not rhTRIM5alpha-expressing cells. Our results suggest that cell-associated HIV transmission in humans is blocked only when both donor and recipient cells express rhTRIM5alpha. These studies further define the role of rhTRIM5alpha in cell-free and cell-associated HIV transmission and delineate the utility of rhTRIM5alpha in anti-HIV therapy.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D044767 Ubiquitin-Protein Ligases A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes. Ubiquitin-Protein Ligase,E3 Ligase,E3 Ubiquitin Ligase,Ubiquitin Ligase E3,Ubiquitin-Protein Ligase E3,Ligase E3, Ubiquitin,Ligase E3, Ubiquitin-Protein,Ligase, E3,Ligase, E3 Ubiquitin,Ligase, Ubiquitin-Protein,Ligases, Ubiquitin-Protein,Ubiquitin Ligase, E3,Ubiquitin Protein Ligase,Ubiquitin Protein Ligase E3,Ubiquitin Protein Ligases
D018920 Coculture Techniques A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states. Cocultivation,Co-culture,Coculture,Co culture,Co-cultures,Cocultivations,Coculture Technique,Cocultures

Related Publications

Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
March 2008, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
September 2005, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
March 2006, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
January 2010, PLoS pathogens,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
May 1999, The Journal of infectious diseases,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
January 1996, Epidemiologic reviews,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
December 2005, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
March 2006, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
December 2008, Journal of virology,
Max W Richardson, and Richard G Carroll, and Matthew Stremlau, and Nikolay Korokhov, and Laurent M Humeau, and Guido Silvestri, and Joseph Sodroski, and James L Riley
December 1988, Journal of virology,
Copied contents to your clipboard!